[go: up one dir, main page]

DE69840816D1 - Isochinoline und deren Herstellung - Google Patents

Isochinoline und deren Herstellung

Info

Publication number
DE69840816D1
DE69840816D1 DE69840816T DE69840816T DE69840816D1 DE 69840816 D1 DE69840816 D1 DE 69840816D1 DE 69840816 T DE69840816 T DE 69840816T DE 69840816 T DE69840816 T DE 69840816T DE 69840816 D1 DE69840816 D1 DE 69840816D1
Authority
DE
Germany
Prior art keywords
isoquinolines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840816T
Other languages
English (en)
Inventor
John-Joseph Cornell Rese Savarese
Roy-Archibald Swaringen Jr
Vincente Samano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Avera Pharmaceuticals Inc
Original Assignee
Cornell Research Foundation Inc
Avera Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Cornell Research Foundation Inc, Avera Pharmaceuticals Inc filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of DE69840816D1 publication Critical patent/DE69840816D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69840816T 1997-03-25 1998-03-23 Isochinoline und deren Herstellung Expired - Lifetime DE69840816D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers

Publications (1)

Publication Number Publication Date
DE69840816D1 true DE69840816D1 (de) 2009-06-18

Family

ID=26311255

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69819703T Expired - Lifetime DE69819703T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
DE69840816T Expired - Lifetime DE69840816D1 (de) 1997-03-25 1998-03-23 Isochinoline und deren Herstellung
DE69830157T Expired - Lifetime DE69830157T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69819703T Expired - Lifetime DE69819703T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69830157T Expired - Lifetime DE69830157T2 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker

Country Status (36)

Country Link
US (2) US6177445B1 (de)
EP (4) EP1526130A1 (de)
JP (3) JP4112016B2 (de)
KR (2) KR100578443B1 (de)
CN (1) CN1203061C (de)
AP (1) AP1797A (de)
AR (1) AR012156A1 (de)
AT (3) ATE430734T1 (de)
AU (2) AU745382B2 (de)
BR (1) BR9808422B1 (de)
CA (1) CA2284802C (de)
CO (1) CO4940499A1 (de)
CZ (1) CZ293786B6 (de)
DE (3) DE69819703T2 (de)
DK (2) DK0971898T3 (de)
EA (1) EA002224B1 (de)
EE (1) EE04113B1 (de)
ES (2) ES2242275T3 (de)
HR (1) HRP980157B1 (de)
HU (1) HU228230B1 (de)
ID (1) ID22901A (de)
IL (1) IL131918A (de)
IS (2) IS2346B (de)
MA (1) MA26476A1 (de)
MY (1) MY121316A (de)
NO (1) NO314726B1 (de)
NZ (1) NZ337797A (de)
PE (1) PE68399A1 (de)
PL (1) PL190860B1 (de)
PT (2) PT971898E (de)
RS (1) RS49869B (de)
SI (1) SI0975599T1 (de)
TR (1) TR199902330T2 (de)
TW (1) TW505635B (de)
UY (1) UY24933A1 (de)
WO (2) WO1998042674A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100578443B1 (ko) * 1997-03-25 2006-05-11 아베라 파마슈티칼스, 인크. 초단기 작용성 신경근 차단제인 치환된 이소퀴놀린
US6911455B2 (en) * 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
EP1684753A2 (de) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuskuläre blockiermittel und ihre antagonisten
CA2671904C (en) * 2006-12-06 2012-07-03 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
BRPI0808272A2 (pt) 2007-03-08 2014-07-08 Chemagis Ltd "método para cromatograficamente separar o isômero 1r-cis, 1´r-cis de uma mistura de isômeros de (1r-1'r) - atracúrio, besilato de cisatracúrio e isômero 1r-cis, 1'r-cis do besilato de cisatracúrio"
WO2008117271A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
BRPI0809892A2 (pt) * 2007-05-01 2014-09-30 Chemagis Ltd Composto de isoquinolínio, forma cristalina, composto cristalino (vii) e método para preparar cis-atracúrio
AU2008243749B2 (en) * 2007-05-01 2012-05-03 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
WO2009007946A1 (en) * 2007-07-09 2009-01-15 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
CA2687157A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
AU2008320380A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
US9156826B2 (en) * 2012-06-29 2015-10-13 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成(r)-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
PL121492B1 (en) * 1977-08-01 1982-05-31 Massachusetts Gen Hospital Process for preparing novel salts of bis-tetrahydroisoquinolinium-alkyl m-or p-phenylene-dialkanocarboxylatessilanov bis-tetragidroizokhinolino-alkilovykh solejj
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
KR100578443B1 (ko) * 1997-03-25 2006-05-11 아베라 파마슈티칼스, 인크. 초단기 작용성 신경근 차단제인 치환된 이소퀴놀린

Also Published As

Publication number Publication date
EE9900424A (et) 2000-04-17
AR012156A1 (es) 2000-09-27
DE69830157D1 (de) 2005-06-16
JP2008019272A (ja) 2008-01-31
EE04113B1 (et) 2003-08-15
DK0971898T3 (da) 2005-09-05
IS8717A (is) 2008-03-03
HK1023342A1 (en) 2000-09-08
US6187789B1 (en) 2001-02-13
IL131918A (en) 2005-09-25
PL335885A1 (en) 2000-05-22
EP1526130A1 (de) 2005-04-27
IS2346B (is) 2008-03-15
HRP980157B1 (en) 2004-10-31
IS5185A (is) 1999-09-17
DK0975599T3 (da) 2004-03-15
EP0975599A1 (de) 2000-02-02
JP4112015B2 (ja) 2008-07-02
WO1998042674A1 (en) 1998-10-01
AP1797A (en) 2007-11-15
CA2284802C (en) 2009-06-16
JP4112016B2 (ja) 2008-07-02
KR100578443B1 (ko) 2006-05-11
JP2002503220A (ja) 2002-01-29
AU7521098A (en) 1998-10-20
KR20050103984A (ko) 2005-11-01
NZ337797A (en) 2001-03-30
DE69819703T2 (de) 2004-09-30
BR9808422A (pt) 2000-05-23
KR20010005621A (ko) 2001-01-15
HUP0001556A2 (hu) 2001-04-28
EP0971898A1 (de) 2000-01-19
PT971898E (pt) 2005-07-29
MY121316A (en) 2006-01-28
ATE254107T1 (de) 2003-11-15
TW505635B (en) 2002-10-11
AU745382B2 (en) 2002-03-21
EP1380573A2 (de) 2004-01-14
EP1380573B1 (de) 2009-05-06
KR100554601B1 (ko) 2006-03-03
AP9901658A0 (en) 1999-09-30
AU6730598A (en) 1998-10-20
MA26476A1 (fr) 2004-12-20
ES2210757T3 (es) 2004-07-01
HRP980157A2 (en) 1999-02-28
DE69819703D1 (de) 2003-12-18
EA199900756A1 (ru) 2000-08-28
ES2242275T3 (es) 2005-11-01
RS49869B (sr) 2008-08-07
SI0975599T1 (en) 2004-04-30
TR199902330T2 (xx) 2000-02-21
ATE430734T1 (de) 2009-05-15
NO314726B1 (no) 2003-05-12
UY24933A1 (es) 2000-12-29
CN1257483A (zh) 2000-06-21
BR9808422B1 (pt) 2010-08-24
IL131918A0 (en) 2001-03-19
JP2002517168A (ja) 2002-06-11
CO4940499A1 (es) 2000-07-24
CZ340499A3 (cs) 2000-04-12
EP1380573A3 (de) 2004-01-21
ATE295351T1 (de) 2005-05-15
CA2284802A1 (en) 1998-10-01
EP0971898B1 (de) 2005-05-11
PL190860B1 (pl) 2006-02-28
DE69830157T2 (de) 2006-05-11
WO1998042675A1 (en) 1998-10-01
NO994680D0 (no) 1999-09-24
EP0975599B1 (de) 2003-11-12
EA002224B1 (ru) 2002-02-28
PE68399A1 (es) 1999-07-23
CZ293786B6 (cs) 2004-07-14
NO994680L (no) 1999-11-24
ID22901A (id) 1999-12-16
YU48399A (sh) 2002-06-19
HU228230B1 (en) 2013-02-28
US6177445B1 (en) 2001-01-23
HUP0001556A3 (en) 2002-01-28
PT975599E (pt) 2004-03-31
CN1203061C (zh) 2005-05-25

Similar Documents

Publication Publication Date Title
DE69840816D1 (de) Isochinoline und deren Herstellung
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
DE69842210D1 (de) Einführvorrichtung Und Einführungssatz
EP0790826A4 (de) Dyhydropyrimidine und deren verwendungen
DE69838849D1 (de) Mehrchipmodulstruktur und seine herstellung
DE69509574D1 (de) Silikonvesikeln und Einschlussprodukte
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DE69833739D1 (de) Kosmetisches Präparat
DE69831750D1 (de) Biozide und biozide tücher
NO965539D0 (no) Farmasöytiske tacrinepreparater
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69830119D1 (de) Teigzusammensetzung und derer Herstellung
EE9800339A (et) Aminoisokinoliinid ja aminotienopüridiini derivaadid ning nende kasutamine põletikuvastaste ainetena
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
DE69809091D1 (de) Phenylphosphonsäurederivate und deren Herstellung
BR9509688A (pt) Composto e composição farmacêutica
DE69716696D1 (de) Vielfächiger ordner und multi-ordner
ATE270272T1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
DE69732139D1 (de) Lösungsvermittler, emulgatoren und dispergiermittel
DE69513225D1 (de) Insektizide und akarizide Mittel
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
DE69710924D1 (de) Insektizide und akarizide mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition